Mediwatch (MDW)

 3.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.35
  • 52 Week Low: 1.75
  • Currency: UK Pounds
  • Shares Issued: 140.87m
  • Volume: 0
  • Market Cap: £4.58m
  • RiskGrade: 363
  • Beta: 0.18

Latest ShareCast News

Small caps round-up: Mediwatch, Mediterranean Oil, Kea ...

By Natasha Roberts

Date: Wednesday 01 Feb 2012

Mediwatch, a urological diagnostic firm, has reported a rise in pre-tax profit (PTP) up from £0.23m to £0.32m for the year ending October 31st. Sales revenue rose from £10.5m to £10.6m, while cash flow from operations jumped £0.58m to £0.84m. The company attributed the rise in PTP to the re-organisation which began in the first quarter of 2011, as it has enabled the firm to invest in new markets, products and services. The company also saw 75% sales growth in developing markets.

Mediwatch Regulatory News

Directors' Shareholdings 23-Apr-2012 16:56 RNS
Result of AGM 20-Apr-2012 11:49 RNS
Director's Shareholding 30-Mar-2012 15:42 RNS
Directorate Changes 27-Mar-2012 07:00 RNS
Directorate Changes 05-Mar-2012 07:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Mediwatch Market Data

Currency UK Pounds
Share Price 3.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.35
52 Week Low 1.75
Volume 0
Shares Issued 140.87m
Market Cap £4.58m
Beta 0.18
RiskGrade 363

Mediwatch Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.61% above the market average51.61% above the market average51.61% above the market average51.61% above the market average51.61% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Price Trend
56.92% above the market average56.92% above the market average56.92% above the market average56.92% above the market average56.92% above the market average
57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average57.14% above the sector average
Income Not Available
Growth
83.06% below the market average83.06% below the market average83.06% below the market average83.06% below the market average83.06% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Mediwatch Dividends

No dividends found

Trades for --2012

Time Volume / Share Price
0 @ 0.000p

Mediwatch Key Personnel

CEO Philip G Stimpson

Top of Page